The pain patch market size has grown strongly in recent years. It will grow from $4.44 billion in 2025 to $4.74 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to increasing prevalence of chronic pain conditions, rising post-surgical pain management needs, growth of outpatient treatment settings, wider availability of transdermal therapies, patient preference for non-invasive treatments.
The pain patch market size is expected to see strong growth in the next few years. It will grow to $6.29 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing focus on opioid alternatives, rising investments in advanced drug delivery systems, expansion of personalized pain therapies, growing demand for sustained-release formulations, increasing adoption of self-administered treatments. Major trends in the forecast period include increasing adoption of non-opioid pain management solutions, rising use of microneedle patch technologies, growing demand for long-acting transdermal therapies, expansion of home-based pain management, enhanced focus on controlled drug delivery.
The rising prevalence of pain disorders is expected to significantly boost the growth of the pain patch market. Pain disorders encompass various conditions where pain is the primary symptom, often caused by psychological stress, inflammatory diseases, or physical trauma. Pain patches offer a targeted solution by delivering medication directly through the skin into the bloodstream, providing controlled and sustained relief over an extended period. For instance, in October 2024, according to the National Library of Medicine, a US-based biomedical library, in 2023, 24.3% of adults experienced chronic pain, while 8.5% reported high-impact chronic pain over the past three months. Therefore, the rise in pain disorders will continue to drive the growth of the pain patch market.
Major companies operating in the pain patch market are also investing in the development of reusable pain patch products to enhance profitability. Reusable pain patch products are designed for multiple uses without compromising their efficacy in pain management. In November 2023, Signal Relief, a US-based pain management solutions provider, launched the Signal Relief Pain Patch. This drug-free and non-invasive pain relief patch utilizes microscopic particles as pain signal antennas to reroute and interrupt pain messages, providing long-lasting relief. The reusable nature of the patch, coupled with its wireless and chemical-free design, offers an innovative approach to pain management.
In July 2024, Grünenthal, a Germany-based pharmaceutical company, announced the acquisition of Valinor Pharma for $250 million. This strategic move is intended to enhance Grünenthal's portfolio in pain management and bolster its capabilities in creating innovative therapies for patients with unmet medical needs. Valinor Pharma, a Canada-based biotechnology company, specializes in developing therapies for rare diseases and complex medical conditions, aligning well with Grünenthal's focus on advancing treatment options in the pain management sector. This acquisition reflects Grünenthal's commitment to expanding its impact in the pharmaceutical market, particularly in addressing challenging medical issues.
Major companies operating in the pain patch market are Pfizer Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline plc, Viatris Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Hikma Pharmaceuticals plc, Endo International plc, Amneal Pharmaceuticals LLC, Grünenthal Group, Allergan plc, Hisamitsu Pharmaceutical Co. Inc., NICHIBAN Co. Ltd., Teikoku Seiyaku Co. Ltd., Haw Par Corporation, Sorrento Therapeutics Inc., Nanjing Joyful Industrial Co. Ltd., NEXGEL Inc.
North America was the largest region in the pain patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pain patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pain patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the pain patch market by increasing costs of imported active pharmaceutical ingredients, transdermal polymers, adhesive materials, and specialized packaging components. Pharmaceutical manufacturers in North America and Europe are most affected due to dependence on imported raw materials, while Asia-Pacific faces export-related cost pressures. These tariffs are increasing production expenses and influencing pricing strategies for pain management products. However, they are also encouraging domestic API production, localized formulation development, and investment in regional pharmaceutical manufacturing capabilities.
The pain patch market research report is one of a series of new reports that provides pain patch market statistics, including pain patch industry global market size, regional shares, competitors with a pain patch market share, detailed pain patch market segments, market trends and opportunities, and any further data you may need to thrive in the pain patch industry. This pain patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A pain patch is a transdermal medication designed for the management of acute and chronic pain. It is utilized to alleviate severe pain, such as chronic pain or post-surgical pain, by delivering consistent doses of medication into the bloodstream through the skin.
The primary types of pain patches include opioid and non-opioid patches. Opioids are a class of drugs used to alleviate moderate to severe pain. Opioid patches are employed in pain management to address severe pain with minimal side effects. These patches are administered through metered-dose and microneedle patches, serving purposes such as pain relief, anesthesia, smoking cessation, cough suppression, and diarrhea suppression. Distribution of these patches occurs through various channels, including online pharmacies, retail pharmacies, and hospital pharmacies.
The pain patch market consists of sales of fentanyl patches, clonidine patches, nitroglycerin patches, buprenorphine, diclofenac patches, lidocaine patches, ketoprofen patches, capsaicin patches, and methyl salicylate patches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The pain patch market size is expected to see strong growth in the next few years. It will grow to $6.29 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing focus on opioid alternatives, rising investments in advanced drug delivery systems, expansion of personalized pain therapies, growing demand for sustained-release formulations, increasing adoption of self-administered treatments. Major trends in the forecast period include increasing adoption of non-opioid pain management solutions, rising use of microneedle patch technologies, growing demand for long-acting transdermal therapies, expansion of home-based pain management, enhanced focus on controlled drug delivery.
The rising prevalence of pain disorders is expected to significantly boost the growth of the pain patch market. Pain disorders encompass various conditions where pain is the primary symptom, often caused by psychological stress, inflammatory diseases, or physical trauma. Pain patches offer a targeted solution by delivering medication directly through the skin into the bloodstream, providing controlled and sustained relief over an extended period. For instance, in October 2024, according to the National Library of Medicine, a US-based biomedical library, in 2023, 24.3% of adults experienced chronic pain, while 8.5% reported high-impact chronic pain over the past three months. Therefore, the rise in pain disorders will continue to drive the growth of the pain patch market.
Major companies operating in the pain patch market are also investing in the development of reusable pain patch products to enhance profitability. Reusable pain patch products are designed for multiple uses without compromising their efficacy in pain management. In November 2023, Signal Relief, a US-based pain management solutions provider, launched the Signal Relief Pain Patch. This drug-free and non-invasive pain relief patch utilizes microscopic particles as pain signal antennas to reroute and interrupt pain messages, providing long-lasting relief. The reusable nature of the patch, coupled with its wireless and chemical-free design, offers an innovative approach to pain management.
In July 2024, Grünenthal, a Germany-based pharmaceutical company, announced the acquisition of Valinor Pharma for $250 million. This strategic move is intended to enhance Grünenthal's portfolio in pain management and bolster its capabilities in creating innovative therapies for patients with unmet medical needs. Valinor Pharma, a Canada-based biotechnology company, specializes in developing therapies for rare diseases and complex medical conditions, aligning well with Grünenthal's focus on advancing treatment options in the pain management sector. This acquisition reflects Grünenthal's commitment to expanding its impact in the pharmaceutical market, particularly in addressing challenging medical issues.
Major companies operating in the pain patch market are Pfizer Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline plc, Viatris Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Hikma Pharmaceuticals plc, Endo International plc, Amneal Pharmaceuticals LLC, Grünenthal Group, Allergan plc, Hisamitsu Pharmaceutical Co. Inc., NICHIBAN Co. Ltd., Teikoku Seiyaku Co. Ltd., Haw Par Corporation, Sorrento Therapeutics Inc., Nanjing Joyful Industrial Co. Ltd., NEXGEL Inc.
North America was the largest region in the pain patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pain patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pain patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the pain patch market by increasing costs of imported active pharmaceutical ingredients, transdermal polymers, adhesive materials, and specialized packaging components. Pharmaceutical manufacturers in North America and Europe are most affected due to dependence on imported raw materials, while Asia-Pacific faces export-related cost pressures. These tariffs are increasing production expenses and influencing pricing strategies for pain management products. However, they are also encouraging domestic API production, localized formulation development, and investment in regional pharmaceutical manufacturing capabilities.
The pain patch market research report is one of a series of new reports that provides pain patch market statistics, including pain patch industry global market size, regional shares, competitors with a pain patch market share, detailed pain patch market segments, market trends and opportunities, and any further data you may need to thrive in the pain patch industry. This pain patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A pain patch is a transdermal medication designed for the management of acute and chronic pain. It is utilized to alleviate severe pain, such as chronic pain or post-surgical pain, by delivering consistent doses of medication into the bloodstream through the skin.
The primary types of pain patches include opioid and non-opioid patches. Opioids are a class of drugs used to alleviate moderate to severe pain. Opioid patches are employed in pain management to address severe pain with minimal side effects. These patches are administered through metered-dose and microneedle patches, serving purposes such as pain relief, anesthesia, smoking cessation, cough suppression, and diarrhea suppression. Distribution of these patches occurs through various channels, including online pharmacies, retail pharmacies, and hospital pharmacies.
The pain patch market consists of sales of fentanyl patches, clonidine patches, nitroglycerin patches, buprenorphine, diclofenac patches, lidocaine patches, ketoprofen patches, capsaicin patches, and methyl salicylate patches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Pain Patch Market Characteristics
3. Pain Patch Market Supply Chain Analysis
4. Global Pain Patch Market Trends and Strategies
5. Pain Patch Market Analysis of End Use Industries
7. Global Pain Patch Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Pain Patch Total Addressable Market (TAM) Analysis for the Market
9. Pain Patch Market Segmentation
10. Pain Patch Market Regional and Country Analysis
11. Asia-Pacific Pain Patch Market
12. China Pain Patch Market
13. India Pain Patch Market
14. Japan Pain Patch Market
15. Australia Pain Patch Market
16. Indonesia Pain Patch Market
17. South Korea Pain Patch Market
18. Taiwan Pain Patch Market
19. South East Asia Pain Patch Market
20. Western Europe Pain Patch Market
21. UK Pain Patch Market
22. Germany Pain Patch Market
23. France Pain Patch Market
24. Italy Pain Patch Market
25. Spain Pain Patch Market
26. Eastern Europe Pain Patch Market
27. Russia Pain Patch Market
28. North America Pain Patch Market
29. USA Pain Patch Market
30. Canada Pain Patch Market
31. South America Pain Patch Market
32. Brazil Pain Patch Market
33. Middle East Pain Patch Market
34. Africa Pain Patch Market
36. Pain Patch Market Competitive Landscape and Company Profiles
37. Pain Patch Market Other Major and Innovative Companies
40. Pain Patch Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Pain Patch Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses pain patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pain patch? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pain patch market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Opioid; Non-Opioid2) By Route Of Administration: Metered Dose; Microneedle Patches
3) By Distribution Channel: Online Pharmacies; Retail Pharmacies; Hospital Pharmacies
Subsegments:
1) By Opioid: Fentanyl Patches; Buprenorphine Patches2) By Non-Opioid: Lidocaine Patches; Capsaicin Patches; Diclofenac Patches
Companies Mentioned: Pfizer Inc.; Bayer AG; Novartis AG; Sanofi S.A.; GlaxoSmithKline plc; Viatris Inc.; Mylan N.V.; Sun Pharmaceutical Industries Ltd.; Perrigo Company plc; Hikma Pharmaceuticals plc; Endo International plc; Amneal Pharmaceuticals LLC; Grünenthal Group; Allergan plc; Hisamitsu Pharmaceutical Co. Inc.; NICHIBAN Co. Ltd.; Teikoku Seiyaku Co. Ltd.; Haw Par Corporation; Sorrento Therapeutics Inc.; Nanjing Joyful Industrial Co. Ltd.; NEXGEL Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Pain Patch market report include:- Pfizer Inc.
- Bayer AG
- Novartis AG
- Sanofi S.A.
- GlaxoSmithKline plc
- Viatris Inc.
- Mylan N.V.
- Sun Pharmaceutical Industries Ltd.
- Perrigo Company plc
- Hikma Pharmaceuticals plc
- Endo International plc
- Amneal Pharmaceuticals LLC
- Grünenthal Group
- Allergan plc
- Hisamitsu Pharmaceutical Co. Inc.
- NICHIBAN Co. Ltd.
- Teikoku Seiyaku Co. Ltd.
- Haw Par Corporation
- Sorrento Therapeutics Inc.
- Nanjing Joyful Industrial Co. Ltd.
- NEXGEL Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.74 Billion |
| Forecasted Market Value ( USD | $ 6.29 Billion |
| Compound Annual Growth Rate | 7.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
